1,384 Shares in Chemed Corporation $CHE Acquired by Wilian Securities LLC

Wilian Securities LLC acquired a new position in Chemed Corporation (NYSE:CHE) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,384 shares of the company’s stock, valued at approximately $592,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Alps Advisors Inc. lifted its stake in Chemed by 32.4% in the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock valued at $19,833,000 after buying an additional 10,845 shares during the period. Van Berkom & Associates Inc. lifted its stake in Chemed by 33.0% in the third quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after buying an additional 42,390 shares during the period. SG Americas Securities LLC lifted its stake in Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after buying an additional 23,436 shares during the period. Vest Financial LLC lifted its stake in Chemed by 32.6% in the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock valued at $4,344,000 after buying an additional 2,383 shares during the period. Finally, Envestnet Asset Management Inc. lifted its stake in Chemed by 6.5% in the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after buying an additional 4,865 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 3.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CHE shares. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Chemed has an average rating of “Hold” and a consensus target price of $501.50.

Chemed Trading Down 0.0%

NYSE CHE opened at $441.58 on Friday. The business has a 50 day moving average price of $399.53 and a 200-day moving average price of $424.95. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $581.20. The company has a market cap of $5.86 billion, a price-to-earnings ratio of 24.06, a P/E/G ratio of 1.66 and a beta of 0.54. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the prior year, the company posted $5.63 earnings per share. Chemed’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be issued a dividend of $0.60 per share. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio is 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.